Vivicells International Stock Buy Hold or Sell Recommendation
| VCII Stock | USD 0.0001 0.00 0.000003% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding ViviCells International is 'Strong Sell'. The recommendation algorithm takes into account all of ViviCells International's available fundamental, technical, and predictive indicators you will find on this site.
Check out ViviCells International Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in ViviCells Stock please use our How to Invest in ViviCells International guide. In addition, we conduct extensive research on individual companies such as ViviCells and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards ViviCells International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
ViviCells | Build AI portfolio with ViviCells Stock |
Execute ViviCells International Buy or Sell Advice
The ViviCells recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on ViviCells International. Macroaxis does not own or have any residual interests in ViviCells International or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute ViviCells International's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
ViviCells International Trading Alerts and Improvement Suggestions
| ViviCells International generated a negative expected return over the last 90 days | |
| ViviCells International has some characteristics of a very speculative penny stock | |
| ViviCells International has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 3.77 M. Net Loss for the year was (14.44 K) with profit before overhead, payroll, taxes, and interest of 1.13 M. | |
| ViviCells International currently holds about 10.26 K in cash with (1.21 M) of positive cash flow from operations. | |
| ViviCells International has a very weak financial position based on the latest SEC disclosures |
ViviCells International Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to ViviCells International or Independent Power and Renewable Electricity Producers sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that ViviCells International's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ViviCells stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
ViviCells International Volatility Alert
At this time ViviCells International exhibits very low volatility. ViviCells International appears to be a penny stock. Although ViviCells International may be, in fact, a solid short-term or long term investment, many penny stocks are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in ViviCells International or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on ViviCells instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.ViviCells International Fundamentals Vs Peers
Comparing ViviCells International's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze ViviCells International's direct or indirect competition across all of the common fundamentals between ViviCells International and the related equities. This way, we can detect undervalued stocks with similar characteristics as ViviCells International or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of ViviCells International's fundamental indicators could also be used in its relative valuation, which is a method of valuing ViviCells International by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare ViviCells International to competition |
| Fundamentals | ViviCells International | Peer Average |
| Profit Margin | (0.09) % | (1.27) % |
| Operating Margin | 0.46 % | (5.51) % |
| Current Valuation | 46.77 K | 16.62 B |
| Shares Outstanding | 233.88 M | 571.82 M |
| Price To Sales | 0 X | 11.42 X |
| Revenue | 3.77 M | 9.43 B |
| Gross Profit | 1.13 M | 27.38 B |
| EBITDA | 294.18 K | 3.9 B |
| Net Income | (14.44 K) | 570.98 M |
| Cash And Equivalents | 10.26 K | 2.7 B |
| Total Debt | 22.31 K | 5.32 B |
| Debt To Equity | 1.07 % | 48.70 % |
| Current Ratio | 5.01 X | 2.16 X |
| Cash Flow From Operations | (1.21 M) | 971.22 M |
| Beta | 43.34 | -0.15 |
| Market Capitalization | 23.39 K | 19.03 B |
| Total Asset | 5.32 M | 29.47 B |
| Working Capital | 2.48 M | 1.48 B |
| Current Asset | 6.6 M | 9.34 B |
| Current Liabilities | 4.12 M | 7.9 B |
| Net Asset | 5.32 M |
ViviCells International Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as ViviCells . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
About ViviCells International Buy or Sell Advice
When is the right time to buy or sell ViviCells International? Buying financial instruments such as ViviCells Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having ViviCells International in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Healthcare Thematic Idea Now
Healthcare
Companies that provide healthcare goods and services including hospitals, health maintenance organizations, HMOs, or medical aid manufacturers. The Healthcare theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.
| View All Next | Launch |
Check out ViviCells International Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in ViviCells Stock please use our How to Invest in ViviCells International guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Independent Power and Renewable Electricity Producers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ViviCells International. If investors know ViviCells will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ViviCells International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Revenue Growth (0.27) |
The market value of ViviCells International is measured differently than its book value, which is the value of ViviCells that is recorded on the company's balance sheet. Investors also form their own opinion of ViviCells International's value that differs from its market value or its book value, called intrinsic value, which is ViviCells International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ViviCells International's market value can be influenced by many factors that don't directly affect ViviCells International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ViviCells International's value and its price as these two are different measures arrived at by different means. Investors typically determine if ViviCells International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ViviCells International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.